Beijing Huafeng Test & Control Technology's (688200.SH) Chief Financial Officer, Huang Ying, plans to reduce their holdings by no more than 2879 shares.

19:34 08/01/2026

Huafeng Measurement and Control (688200.SH) announced that, due to its own capital arrangement needs, Ms. Huang Ying, the company's Chief Financial Officer, plans to reduce her holdings of the company's shares through centralized competitive trading by a total of no more than 2,879 shares, or 0.0021% of the total share capital of the company.

Beijing Huafeng Test & Control Technology (688200.SH) announced that, due to its own financial arrangements, Ms. Huang Ying, the company's Chief Financial Officer, plans to reduce her total holdings of the company's shares through centralized competitive trading by no more than 2879 shares, or 0.0021% of the company's total share capital.

Yantai Zhenghai Bio-Tech (300653.SZ) has obtained a medical device registration certificate.

HK Stock Market Move | CHUANGXIN IND(02788) increased by more than 7% in the afternoon, the substitution of aluminum for copper is expected to accelerate, the company is expanding its electrolytic aluminum production capacity in Saudi Arabia.

Wanbang Pharmaceutical Holding Group (002082.SZ): The Alzheimer's disease project was selected for the national major scientific and technological innovation drug research and development project.

Yantai Zhenghai Bio-Tech (300653.SZ) has obtained a medical device registration certificate.

Wanbang Pharmaceutical Holding Group (002082.SZ): The Alzheimer's disease project was selected for the national major scientific and technological innovation drug research and development project.